New! Sign up for our email newsletter on Substack.

FDA pushes back on birth control stories

FDA Statement on Effectiveness of Newer Birth Control Pills: “Recent wire service stories about today’s meeting of the FDA Reproductive Health Drugs Advisory Committee have created misperceptions about the effectiveness of newer generation hormonal contraceptives.

“The stories inaccurately report that the products are significantly less effective at preventing pregnancy than those approved decades ago. In fact, the newer generation products are highly effective in preventing pregnancy.

“The stories also mistakenly state that FDA called the meeting to discuss the need for higher standards of efficacy for the newer products.

“In fact, as published in the Federal Register Notice announcing this meeting, the purpose of this two-day meeting is to discuss clinical trial designs that reflect the diversity of users of hormonal contraceptives, expectations for efficacy and safety, and user acceptability of the newer generation products, including cycle control.”

From U.S. FDA

Fuel Independent Science Reporting: Make a Difference Today

If our reporting has informed or inspired you, please consider making a donation. Every contribution, no matter the size, empowers us to continue delivering accurate, engaging, and trustworthy science and medical news. Independent journalism requires time, effort, and resources—your support ensures we can keep uncovering the stories that matter most to you.

Join us in making knowledge accessible and impactful. Thank you for standing with us!



Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.